Topical and Oral Voriconazolein the Treatment of Fungal Keratitis
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
We describe two patients with fungal keratitis refractory to standard antifungal therapy whose conditions were managed with voriconazole. The first case is a patient with endophthalmitis and corneal ulcer due to Candida parapsilosis after receiving a corneal transplant. The patient was treated with amphotericin but showed no signs of improvement. Topical voriconazole, oral voriconazole, and intravitreal voriconazole yielded signs of improvement. The second case is a 63-year-old male who underwent a month of empiric treatment with 0.2% topical amphotericin for fungal keratitis but showed no signs of improvement. Treatment was then provided with 1% voriconazole. Both cases showed effective treatment with voriconazole. Voriconazole may be considered as a new method to treat fungal keratitis refractory to standard antifungal therapy.
Abstract
We describe two patients with fungal keratitis refractory to standard antifungal therapy whose conditions were managed with voriconazole. The first case is a patient with endophthalmitis and corneal ulcer due to Candida parapsilosis after receiving a corneal transplant. The patient was treated with amphotericin but showed no signs of improvement. Topical voriconazole, oral voriconazole, and intravitreal voriconazole yielded signs of improvement. The second case is a 63-year-old male who underwent a month of empiric treatment with 0.2% topical amphotericin for fungal keratitis but showed no signs of improvement. Treatment was then provided with 1% voriconazole. Both cases showed effective treatment with voriconazole. Voriconazole may be considered as a new method to treat fungal keratitis refractory to standard antifungal therapy.
참고문헌 (15)
- Anderson KL, "Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair", Cornea, 23, pp.516~521 (2004)
- Shah KB, "Activity of voriconazole against corneal isolates of Scedosporium apiospermum", Cornea, 22, pp.33~36 (2003)
- Ozbek Z, "Voriconazole in the management of Alternaria keratitis", Cornea, 25, pp.242~244 (2006)
- 김경훈, "보리코나졸로 치료한 진균안감염", 대한안과학회지, 49(7), pp.1054~1060 (2008), 대한안과학회
- Jang GJ, "Treatment of Candida Chorioretinitis with Voriconazole", Korean J Ophthalmol, 19, pp.73~76 (2005)
- Sponsel W, "Topical voriconazole as a novel treatment for fungal keratitis", Antimicrob Agents Chemother, 50, pp.262~268 (2006)
- 이성복, "약제 내성을 지닌 페니실리움 안내염에서 유리체강내 보리코나졸 주입술을 이용한 치료 1예", 대한안과학회지, 48(11), pp.1583~1587 (2007), 대한안과학회
- Haripasad SM, "Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans", Arch Ophthalmol, 122, pp.42~47 (2004)
- Marangon FB, "In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens", Am J Ophthalmol, 137, pp.820~825 (2004)
- Gao H, "Safety of intravitreal voriconazole: electroretinographic and histopathologic studies", Trans Am Ophthalmol Soc, 101, pp.183~189 (2003)
- Kramer M, "Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis", Ophthalmology, 113, pp.1184~1186 (2006)
- Herbrecht R, "Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis", N Engl J Med, 347, pp.408~415 (2002)
- Miller GR, "Intravitreal antimycotic therapy and cure of mycotic endophthalmitis caused by Paecilomyces lilacinus contaminated pseudophakos", Ophthalmic Surg, 9, pp.54~63 (1978)
- Ozbek Z, "Voriconazole in the management of Alternaria keratitis", Cornea, 25, pp.242~244 (2006)
- Giaconi JA, "Voriconazole and fungal keratitis: a report of two treatment failures", J Ocul Pharmacol Ther, 22, pp.437~439 (2006)